Cardinal Health, Inc. (CAH) Stock Forecast
CAH analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.47 / 5 from 17 analysts
- Price target
- $271.47 average of analyst targets
- Upside to target
- +6.9% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $2.92
- 52-week range
- $157.27 – $254.06
CAH analyst ratings
17 analystsNumber of analysts at each rating.
CAH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CAH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.94 | $2.88 | $3.06 | $2.55 | +15.3% | 13 |
| Next quarter (Dec '26) | $3.13 | $3.07 | $3.37 | $2.63 | +19.0% | 13 |
| Current fiscal year (FY2027) | $12.56 | $12.51 | $12.74 | $10.95 | +14.8% | 17 |
| Next fiscal year (FY2028) | $14.06 | $13.15 | $14.90 | $12.56 | +11.9% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CAH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $66.51B | $65.08B | $67.25B | +3.9% | 11 |
| Next quarter (Dec '26) | $68.29B | $67.28B | $69.00B | +4.0% | 11 |
| Current fiscal year (FY2027) | $265.77B | $263.54B | $268.34B | +4.5% | 15 |
| Next fiscal year (FY2028) | $281.85B | $273.43B | $292.99B | +6.0% | 15 |
CAH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CAH revenue: reported and forecast
CAH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.90 | $2.94 | $2.94 | $2.94 | $2.94 | +1.2% | 4 up · 3 down |
| Next quarter (Dec '26) | $2.99 | $3.12 | $3.11 | $3.12 | $3.13 | +4.7% | 1 up · 0 down |
| Current fiscal year (FY2027) | $12.05 | $12.55 | $12.57 | $12.56 | $12.56 | +4.3% | 0 up · 1 down |
| Next fiscal year (FY2028) | $13.57 | $14.02 | $14.08 | $14.06 | $14.06 | +3.6% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CAH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CAH beat in 12 of 12.
What analysts expect from CAH
17 analysts cover Cardinal Health; their consensus rating is buy (4.47 on a 1–5 scale, where 5 is a strong buy). The average price target is $271.47, 6.9% above the latest close of $254.06. Analysts expect earnings of $12.56 per share for FY2027, +14.8% from a year earlier. For FY2028 the average estimate is $14.06 per share on revenue of $281.9 billion. Cardinal Health beat the EPS estimate in 12 of the last 12 quarters.
Related: CAH income statement, CAH key metrics, CAH chart. See the CAH stock overview for the latest quote and news.
CAH forecast FAQ
What is Cardinal Health's price target?
The average analyst price target for Cardinal Health is $271.47, 6.9% above the latest close of $254.06.
Is Cardinal Health a buy, hold or sell?
Of 17 analysts covering Cardinal Health, 11 rate it a strong buy, 3 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Cardinal Health's EPS forecast?
Analysts forecast $12.56 per share for FY2027 (range $12.51 to $12.74); for FY2028 the estimate is $14.06.
What is Cardinal Health's revenue forecast?
The average revenue estimate for FY2027 is $265.8 billion, growth of 4.5%; for FY2028 it is $281.9 billion.
When does Cardinal Health report earnings?
Cardinal Health is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $2.92.
Does Cardinal Health usually beat earnings estimates?
Cardinal Health reported EPS at or above the analyst estimate in 12 of the last 12 quarters.